Makale detayı · 2023 · article
New Diacetic Acids Containing Quinazolin‐4(3H)‐one: Synthesis, Characterization, Anticholinergic Properties, DFT Analysis and Molecular Docking Studies
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıChemistry Select
- Katalog eşleşmesi (ISSN)ChemistrySelect
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
- Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)
Özet
Abstract In this study, a new series of quinazolin‐4(3 H )‐ones, which constitute an important part of biologically active heterocyclic compounds, were synthesized with excellent yields (99‐94 %). The structures of the synthesized compounds ( 1 – 14 ) were characterized with Fourier‐transform infrared (FTIR), nuclear magnetic resonance ( 1 H NMR – 13 C NMR), and high‐resolution mass spectroscopy (HRMS). Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibition properties were examined to evaluate the anticholinergic properties of the synthesized compounds. For AChE, molecules showed IC 50 in ranging of 16.27–9.12 μM and K i s in ranging of 19.20±0.68–4.83±0.19 μM. For BChE, molecules showed IC 50 in ranging of 16.77–8.50 μM and K i s in ranging of 10.35±2.15–3.38±0.25 μM. Molecular docking was performed to determine the predicted interactions between the synthesized molecules and enzymes. Additionally, Density‐functional theory (DFT) studies were also carried out to clarify the electronic structures of compounds.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
27atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 50 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2023 Synthesis and Evaluation of Quinazolin-4(3H)-one Derivatives as Multitarget Metabolic Enzyme Inhibitors: A Biochemistry-Oriented Drug DesignAtıf 56 · OpenAlex
- 2023 Synthesis and Evaluation of Quinazolin‐4(3 H )‐one Derivatives as Multitarget Metabolic Enzyme Inhibitors: A Biochemistry‐Oriented Drug DesignAtıf 56 · OpenAlex
- 2023 Synthesis and Evaluation of Quinazolin-4(3H)-one Derivatives as Multitarget Metabolic Enzyme Inhibitors: A Biochemistry-Oriented Drug DesignAtıf 56 · OpenAlex
- 2025 Development of phenolic Mannich bases as α-glucosidase and aldose reductase inhibitors: In vitro and in silico approaches for managing diabetes mellitus and its complicationsAtıf 45 · OpenAlex
- 2025 New Quinazolin‐4(3H)‐One–Thiazolidine‐2,4‐Dione Hybrids as Dual Inhibitors of α‐Glycosidase and Aldose Reductase: The Synthetic, In Vitro, and In Silico ApproachesAtıf 37 · OpenAlex
- 2025 New Quinazolin‐4(3H)‐One–Thiazolidine‐2,4‐Dione Hybrids as Dual Inhibitors of α‐Glycosidase and Aldose Reductase: The Synthetic, In Vitro, and In Silico ApproachesAtıf 36 · OpenAlex
- 2025 New Quinazolin-4(3H)-One–Thiazolidine-2,4-Dione Hybrids as Dual Inhibitors of α-Glycosidase and Aldose Reductase: The Synthetic, In Vitro, and In Silico ApproachesAtıf 34 · OpenAlex
- 2025 Quinazolin‐4(3H)‐One‐Based New Glitazones as Dual Inhibitors of α‐Glucosidase and Aldose Reductase: Comprehensive Approaches for Managing Diabetes Mellitus and Its ComplicationsAtıf 32 · OpenAlex
- 2025 Quinazolin‐4(3H)‐One‐Based New Glitazones as Dual Inhibitors of α‐Glucosidase and Aldose Reductase: Comprehensive Approaches for Managing Diabetes Mellitus and Its ComplicationsAtıf 30 · OpenAlex
- 2025 New Mannich-type arylidenerhodanines as potent inhibitors of AChE and BChE: synthesis, biological evaluation, cytotoxicity and molecular modelingAtıf 23 · OpenAlex